Home › Funds › Englebert Financial Advisers, LLC › GEHC

Englebert Financial Advisers, LLC position in GEHC

GE HEALTHCARE TECHNOLOGIES I · Health Care

Englebert Financial Advisers, LLC reported holding 7,829 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q2 2026 13F filing — a position valued at US$501K, representing 0.50% of its reported portfolio and ranking #39 among its reported holdings. Englebert Financial Advisers, LLC has disclosed GEHC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)7.83K sh
Reported value held$501.13K
Portfolio Weight0.50%
First reportedQ4 2025
Last changeNew

How Englebert Financial Advisers, LLC's GEHC position evolved

Englebert Financial Advisers, LLC first disclosed a stake in GEHC in Q4 2025 at 8,469 shares (US$695K). Across 3 filings, Englebert Financial Advisers, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,829 shares valued at US$501K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 8.47K $694.63K New
Q1 2026 8.38K $596.35K Reduce
Q2 2026 7.83K $501.13K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GEHC and 13F data

GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GEHC

All GEHC fund holders →